Featured
September 23, 2019
Workshops Invite Input on Diversity
Brian Gittens, Ed.D., who joined UAMS in June as its new vice chancellor for diversity, equity and inclusion, hosted two town hall-style meetings to welcome dozens of employees and students to help shape his division’s strategic plan to invite and support greater diversity on campus. Both workshops were part of the Division of Diversity, Equity…
September 20, 2019
UAMS Acquires Technology that Emulates Human Biologic Responses
UAMS has acquired Emulate Inc.’s Organs-on-Chip technology, which simulates human biology so researchers can better understand how diseases, medicines, chemicals and foods affect human health. The Chip technology can be used for studies on the liver, kidney, lungs and gut, as well as thrombosis and the blood-brain barrier. For example, Emulate’s Liver-Chip can be used…
UAMS First Hospital in Arkansas Approved to Provide Breakthrough CAR T-Cell Therapy for Non-Hodgkin Lymphoma
LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS) is the first and only hospital in Arkansas approved to provide a revolutionary new therapy for certain types of non-Hodgkin lymphoma. Chimeric antigen receptor (CAR) T-cell therapy uses new technology to genetically modify a patient’s own T cells, enabling them to seek and destroy…
September 19, 2019
UAMS, Community Groups Discuss Helping Housing Insecure Pregnant Women
Identifying resources for pregnant women who are housing insecure engaged leaders and community groups Sept. 9 at the Supporting Families in Crisis conference held at the Four Points by Sheraton in Little Rock. Over 200 community leaders, faith leaders, students, educators, researchers, health care workers, mothers impacted by homelessness, and organizations who provide services for…
September 17, 2019
Study Co-authored by UAMS Doctor Shows Benefit of Facebook Patient Support Groups in Rare Cancer Research
LITTLE ROCK – An article co-authored by Jerad Gardner, M.D., at the University of Arkansas for Medical Sciences (UAMS) demonstrates the ability to use international Facebook patient support groups to rapidly reach large numbers of rare cancer survivors.
September 16, 2019
Alter G Treadmill Defies Gravity to Help Patients Heal
E-Stem High School Senior Haley Franklin will be at full capacity in time for basketball season following surgery in April to reconstruct a torn anterior cruciate ligament (ACL) in her knee. “It happened when we were going over plays in practice. I bumped into another person and twisted my knee,” Franklin said. “That was in…
September 13, 2019
Michael Birrer, M.D., Ph.D., Named UAMS Winthrop P. Rockefeller Cancer Institute Director
Internationally recognized medical oncologist Michael Birrer, M.D., Ph.D., has been named vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). Birrer specializes in gynecologic cancers and will join the university by the end of the year.
September 12, 2019
Programs Help Prepare Students for Medical Education
A trio of summer programs offered by the UAMS Center for Diversity Affairs have helped prepare a contingent of potential future doctors for medical school. The Pre-Medical Summer Scholars Program, Final MCAT Preparation Program and MedEd Ready all serve students bound for medical school, but each program is tailored to a different point in students’…
Graduate Student Explores Potential of Handheld DNA/RNA Sequencers in Outbreaks
Imagine there’s an outbreak of an infectious disease. Could health officials on the ground harness the power of new handheld DNA and RNA sequencers to monitor outbreaks in real-time and quickly contain them? This question lies at the heart of research published in the journal Infection, Genetics and Evolution by UAMS graduate student Duah Alkam….
September 10, 2019
UAMS Clinical Trial Shows Promise in New Method for Stroke Treatment
Professor William C. Culp, M.D., and colleagues at the University of Arkansas for Medical Sciences (UAMS) have published promising results from the first human trial of a new drug to treat strokes. If the results of this Phase I clinical trial are repeated in the next phases, the UAMS professors could be responsible for developing…
Previous page Next page